These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7777462)
21. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens. Sachdeva G; Kaur G; Bhutani LK; Bamezai RN Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365 [TBL] [Abstract][Full Text] [Related]
22. Development of giant reaction in response to PPD skin test in lepromatous leprosy patients. Sampaio EP; Duppre NC; Nery JA; Moreira AL; Sarno EN Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):205-13. PubMed ID: 8371029 [TBL] [Abstract][Full Text] [Related]
23. HLA and leprosy in the pre and postgenomic eras. Geluk A; Ottenhoff TH Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267 [TBL] [Abstract][Full Text] [Related]
24. The immunopathology of systemic anergy in infectious diseases: a reappraisal and new perspectives. Bianco NE Clin Immunol Immunopathol; 1992 Mar; 62(3):253-7. PubMed ID: 1541050 [No Abstract] [Full Text] [Related]
25. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. Black GF; Dockrell HM; Crampin AC; Floyd S; Weir RE; Bliss L; Sichali L; Mwaungulu L; Kanyongoloka H; Ngwira B; Warndorff DK; Fine PE J Infect Dis; 2001 Aug; 184(3):322-9. PubMed ID: 11443558 [TBL] [Abstract][Full Text] [Related]
26. T-cell responses against tuberculin and sensitin in children with tuberculosis and non-tuberculosis mycobacterial lymphadenopathy. Magdorf K; Schuck SD; Leitner S; Wahn U; Kaufmann SH; Jacobsen M Clin Microbiol Infect; 2008 Nov; 14(11):1079-83. PubMed ID: 19040480 [TBL] [Abstract][Full Text] [Related]
27. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy. Hussain R; Dockrell HM; Chiang TJ Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976 [TBL] [Abstract][Full Text] [Related]
28. The immunology of mycobacterial infections. Chaparas SD Crit Rev Microbiol; 1982; 9(2):139-97. PubMed ID: 7042210 [TBL] [Abstract][Full Text] [Related]
29. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens. Mohanty KK; Joshi B; Katoch K; Sengupta U Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588 [TBL] [Abstract][Full Text] [Related]
30. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection. Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740 [TBL] [Abstract][Full Text] [Related]
31. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts. Mathew JM; Muthukkaruppan V Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417 [TBL] [Abstract][Full Text] [Related]
32. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients. Chattree V; Khanna N; Rao DN Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060 [TBL] [Abstract][Full Text] [Related]
34. Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy. Hasan Z; Jamil B; Zaidi I; Zafar S; Khan AA; Hussain R Scand J Immunol; 2006 Mar; 63(3):241-7. PubMed ID: 16499578 [TBL] [Abstract][Full Text] [Related]
35. [Use of blast transformation test with different tuberculin dilutions to evaluate functional activity and directivity vector of T-cell activation in patients with tuberculosis during chemotherapy]. Karpov AV; Evdokimov VN; Illarionov VA Probl Tuberk; 1998; (5):42-5. PubMed ID: 9866399 [TBL] [Abstract][Full Text] [Related]
36. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens. Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115 [TBL] [Abstract][Full Text] [Related]
37. An unusual case of untreated lepromatous leprosy with rare bacilli: an immunologic follow-up. Gelber RH; Mohagheghpour N Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):353-4. PubMed ID: 3298482 [No Abstract] [Full Text] [Related]
38. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
39. Biology of the mycobacterioses. A retrospective review of mycobacteria and the diseases they cause. Long ER Ann N Y Acad Sci; 1968 Sep; 154(1):8-12. PubMed ID: 4191743 [No Abstract] [Full Text] [Related]
40. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy. Gormus BJ; Meyers WM Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]